Panacea Life Sciences Holdings, Inc NT 10-Q, filed May 17, 2021
Panacea Life Sciences Holdings, Inc. (PLSH)
NT 10-Q
2021-05-17
For: 2021-03-31
View Original
Added on
October 26, 2026
U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 12b-25
Commission File Number: 001-38190
Notification of
Late Filing
(Check
One):
[ ]
Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form
N-SAR
For
Period Ended: March 31,
2021
|
[
]
|
Transition
Report on Form 10-K
|
|
[
]
|
Transition
Report on Form 20-F
|
|
[
]
|
Transition
Report on Form 11-K
|
|
[
]
|
Transition
Report on Form 10-Q
|
|
[
]
|
Transition
Report on Form N-SAR
|
For the
Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates:
Part I - Registrant Information
|
Exactus, Inc.
Full
Name of Registrant
|
|
__________________________
|
|
Former
Name if Applicable
|
|
80 NE 4th
Ave., Suite 28
|
|
Address
of Principal Executive Office (Street and Number)
|
|
Delray Beach, FL 33483
|
|
City,
State and Zip Code
|
Part II - Rules 12b-25(b) and (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-(b),
the following should be completed. (Check box, if
appropriate)
[X]
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X]
(b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or Form N- SAR, or portion
thereof will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
[ ] (c)
The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III - Narrative
State
below in reasonable detail the reasons why Form 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof could not
be file within the prescribed period.
The Company was unable to compile the necessary financial
information required to prepare a complete filing. Thus, the
Company would be unable to file the periodic report in a timely
manner without unreasonable effort or expense. The Company expects
to file within the extension period.
Part IV - Other Information
(1)
Name and telephone number of person to contract in regard to this
notification.
|
Larry Wert
|
(561)
|
455-4822
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed? If the answer is no, identify
report(s).
[X]
Yes [ ] No
(3) Is
it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? [ ] Yes [X] No
If so:
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Exactus, Inc.
(Name
of Registrant as specified in charter)
has
caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
|
Date:
May 17, 2021
|
By:
/s/ Larry
Wert
|
|
|
Larry
Wert
Its:
Executive Chairman
|